NORTHEAST REGIONAL MEDICAL CENTER

Code	Description	Gross	Cash	Min payer	Max payer	# insurers
510020263	vutrisiran 25 mg/0.5 mL syringe	$424,154	$190,869	—	—	22
510020266	lumasiran 94.5 mg/0.5 mL inj	$407,533	$183,390	—	—	22
510020195	tebentafusp-tebn 100 mcg/0.5 mL inj	$193,897	$87,254	—	—	22
510018653	tagraxofusp-erzs (Elzonris) 1000 mcg inj	$160,682	$72,307	—	—	22
510013649	ustekinumab 45 mg/0.5 mL inj	$135,292	$60,881	—	—	22
510013713	ustekinumab 90 mg/1 mL inj	$135,292	$60,881	—	—	22
510020157	loncastuximab tesirine-lpyl 10 mg inj	$132,168	$59,476	—	—	22
510020127	lanreotide 90 mg syringe	$127,939	$57,573	—	—	22
510017501	ribavirin 6,000 mg Inhalation powder	$118,816	$53,467	—	—	22
510016295	alemtuzumab (Lemtrada) 12 mg/1.2 mL inj	$115,661	$52,047	—	—	22
510018575	inotuzumab ozogamicin 0.9 mg inj	$108,442	$48,799	—	—	22
510017419	porfimer 75 mg Inj	$97,233	$43,755	—	—	22
510018667	polatuzumab vedotin-piiq 140 mg inj	$88,103	$39,646	—	—	22
510018741	fluocinolone acetonide intravitreal 0.59 mg implant	$86,870	$39,092	—	—	22
510018748	teprotumumab-trbw (Tepezza) 500 mg inj	$85,307	$38,388	—	—	22
510016458	vinCRIStine liposome 5 mg/31 mL kit	$74,553	$33,549	—	—	22
510017356	pegloticase 8 mg/1 mL inj	$66,640	$29,988	—	—	22
482561518	ULH PET F-18 AMYVID	$63,000	$28,350	—	—	22
483061518	ULH PET F-18 AMYVID	$63,000	$28,350	—	—	22
510020107	leuprolide (Lupron) 6 Month 45 mg IntraMuscular	$57,793	$26,007	—	—	22
510016642	brentuximab vedotin 50 mg inj	$57,758	$25,991	—	—	22
510018834	luspatercept-aamt 75 mg inj	$57,267	$25,770	—	—	22
510018281	lanreotide 120 mg syringe (J1932/nonpreferred)	$47,790	$21,505	—	—	22
510011289	gemtuzumab ozogamicin 4.5 mg inj	$47,551	$21,398	—	—	22
510016253	vedolizumab 300 mg inj	$44,308	$19,939	—	—	22
510018647	caplacizumab-YHDP (Cablivi) 11 mg inj	$40,577	$18,260	—	—	22
510016572	antivenin (Micrurus fulvius) inj 10 mL	$40,003	$18,001	—	—	22
510010082	alteplase 100 mg/100 mL inj	$39,494	$17,772	—	—	22
510011677	leuprolide (Lupron) 4 Month 30 mg IntraMuscular	$38,528	$17,338	—	—	22
510020033	lurbinectedin 4 mg inj	$38,391	$17,276	—	—	22
510013564	tenecteplase 50 mg inj (myocardial infarction)	$37,145	$16,715	—	—	22
510012316	pegfilgrastim (Neulasta) 6 mg/0.6 mL inj	$35,852	$16,133	—	—	22
510016297	pegfilgrastim (Neulasta) DELIVERY KIT 6 mg/0.6 mL	$35,852	$16,133	—	—	22
470078958	NGS OF DNA & RNA IN TUMOR TISSUE	$35,775	$16,099	—	—	22
510020150	tisotumab vedotin-tftv 40 mg vial	$33,722	$15,175	—	—	22
510018208	talimogene lah 100 million [PFU]/mL	$33,249	$14,962	—	—	22
510020261	teclistamab-cqyv 153 mg/1.7 mL inj	$32,472	$14,613	—	—	22
510010067	alemtuzumab (Campath) 30 mg/1 mL inj	$31,556	$14,200	—	—	22
510020209	pegfilgrastim-BMEZ (Ziextenzo) 6 mg/0.6 mL inj	$31,143	$14,014	—	—	22
510012195	octreotide LAR 30 mg kit	$30,711	$13,820	—	—	22
510015688	ado-trastuzumab emtans 160 mg inj	$30,218	$13,598	—	—	22
510020109	siltuximab 400 mg inj	$30,135	$13,561	—	—	22
510011674	leuprolide (Lupron) 3 Month 22.5 mg IntraMuscular	$28,896	$13,003	—	—	22
510014446	ixabepilone 45 mg inj	$28,610	$12,874	—	—	22
510010878	digoxin immune fab 40 mg inj	$26,543	$11,944	—	—	22
510018213	blinatumomab 35 mcg pwd Inj	$26,302	$11,836	—	—	22
510018635	romiPLOStim 500 mcg/1 mL inj	$26,062	$11,728	—	—	22
510014876	rasburicase 7.5 mg inj	$25,814	$11,616	—	—	22
510018620	pegfilgrastim-CBQV (Udenyca) 6 mg/0.6 mL inj	$25,693	$11,562	—	—	22
510010433	carmustine 7.7 mg wafer	$25,133	$11,310	—	—	22

Showing top 50 of 20,566 priced procedures, sorted by gross charge.

Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.